ILD in the news
06/01/2012 Cholesterol-lowering drug may increase risk of lung problems in smokers
Research has shown a connection between the use of a group of cholesterol-lowering drugs, known as statins, and the development of interstitial lung disease (ILD) in smokers.
More...01/11/2011 Idiopathic Pulmonary Fibrosis survival predicted by a blood protein
A new study has identified a protein found in the blood which could help determine how long a person with idiopathic pulmonary fibrosis (IPF) has left to live.
More...20/09/2011 ATS hold awareness campaign for IPF
The American Thoracic Society (ATS) and the Coalition for Pulmonary Fibrosis (CPF) are holding a two-week national awareness campaign this month (13-24th September 2011) to raise the profile of lethal lung diseases.
More...07/08/2011 Idiopathic Pulmonary Fibrosis (IPF) patients could benefit from heartburn treatment
People with idiopathic pulmonary fibrosis (IPF) could benefit from taking drugs designed to treat heartburn.
More...28/02/2011 Viral infection not responsible for exacerbation of lung disease in most patients
New research has found that viral infections are not responsible for a deterioration of lung disease in most patients.
More...04/03/2010 CT-scan screening for lymphangioleiomyomatosis, or LAM in women with collapsed lung is cost-effective
Researchers at the University of Cincinnati, USA, have found that using high-resolution CT-scans to screen for lymphangioleiomyomatosis, or LAM, is cost-effective in non-smoking women with a collapsed lung.
04/06/2009 Protein may be strongest indicator of rare lung disease
Researchers at the University of Cincinnati (UC), USA, have discovered a protein in the lungs that can help determine the progression of idiopathic pulmonary fibrosis (IPF).
More...01/10/2007 Israeli researcher tells how he became a world expert in idiopathic pulmonary fibrosis
When Dr Naftali Kaminski decided to research idiopathic pulmonary fibrosis (IPF), his mentors tried to talk him out of it. But that only increased his determination.
More...29/03/2007 Johns Hopkins scientists discover genetic roots of hereditary lung disease
Scientists at Johns Hopkins identified the genetic culprits that trigger a hereditary form of a fatal lung disease — idiopathic pulmonary fibrosis.
10/04/2006 Clue to why mortality rates from pulmonary fibrosis are higher among black people
Pulmonary fibrosis (PF) is a deadly, very complex disease characterised by fibrotic growth in the lung’s air sacs. Of the more than 40,000 persons who die each year in the US from pulmonary fibrosis, the mortality rate among African-Americans is twice as high as Caucasians. Researchers at the Department of Medicine, Medical University of South Carolina, USA, may have discovered why.
More... | The news presented here is taken from sources on different websites. A brief summary of the news is given, along with a link to the original article. |
- www.businessdecision.com - Website Partner
-
Copyright:
European Lung Foundation